Impaired Immune Responses Toward Alloantigens and Tumor Cells but Normal Thymic Selection in Mice Deficient in the β2 Integrin Leukocyte Function-Associated Antigen-1

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5375-5386

  Shier, Peter ^a,b   Otulakowski, Gail ^b   Ngo, Karen ^a,b   Panakos, Julie ^b   Chourmouzis, Erika ^b   Christjansen, Lisa ^b   Lau, Catherine Y ^b   Fung Leung, Wai Ping ^a,b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b R W Johnson Pharmaceutical Res I   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL; ARTICLE; CELL AGGREGATION; CYTOLOGY; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; GRAFT REJECTION; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; THYMUS;

ANIMALS; CELL AGGREGATION; CHEMOTAXIS, LEUKOCYTE; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; HYPERSENSITIVITY, DELAYED; INFLAMMATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, KNOCKOUT; NEUTROPHILS; THYMUS GLAND;

EID: 0030589228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Clevers, H., B. Alarcon, T. Wileman, and C. Terhorst. 1988. The T cell receptor/ CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol. 6:629.
2. Kishimoto, T. K., R. S. Larson, A. L. Corbi, M. L. Dustin, D. E. Staunton, and T. A. Springer. 1989. The leukocyte integrins: LFA-1, Mac-1, and p 150,95. Adv. Immunol. 46:149.
3. Larson, T. S., and T. A. Springer. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114:181.
4. Harvey, J. E., N. Hogg, and R. C. Landis. 1993. LFA-1 and the ICAMs. In Lymphocyte Adhesion Molecules. Y. Shimizu, ed. R. G. Landes Co., Austin, p. 26.
5. Krensky, A. M., F. Sanchez-Madrid, E. Robbins, J. A. Nagy, T. A. Springer, and S. J. Burakoff. 1983. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J. Immunol. 131:611.
6. Martz, E. 1987. LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes. Hum. Immunol. 18:3.
7. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
8. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
9. Kurzinger, K., T. Reynolds, R. N. Germain, D. Davignon, E. Martz, and T. A. Springer. 1981. A novel lymphocyte function-associated antigen (LFA-1): cellular distribution, quantitative expression, and structure. J. Immunol. 127:596.
10. Keizer, G. D., J. Borst, C. G. Figdor, H. Spits, F. Miedma, C. Terhorst, and J. E. De Vries. 1985. Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95. Eur. J. Immunol. 15: 1142.
11. Davis, D. E. 1992. The Mac-1 and p 150,95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp. Cell Res. 200:242.
12. Anderson, D. C., and T. A. Springer. 1987. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1 and p 150,95 glycoproteins. Annu. Rev. Med. 38:175.
13. Marlin, S. D., and T. A. Springer. 1987. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813.
14. Staunton, D. E., M. L. Dustin, and T. A. Springer. 1989. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 339: 61.
15. de Fougerolles, A. R., and T. A. Springer. 1992. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J. Exp. Med. 175:185.
16. Dustin, M. L., and T. A. Springer. 1989. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619.
17. van Kooyk, Y., P. van de Wiel-van Kemenade, P. Weder, T. W. Kuijpers, and C. G. Figdor. 1989. Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on lymphocytes. Nature 342:811.
18. van Noesel, C., F. Miedema, M. Brouwer, M. A. de Rie, L. A. Aarden, and R. A. van Lier. 1988. Regulatory properties of LFA-1 a and β chains in human T-lymphocyte activation. Nature 333:850.
19. Pardi, R., J. R. Bender, C. Dettori, E. Giannazza, and E. G. Engleman. 1989. Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J. Immunol. 143:3157.
20. Schwartz, M. A., D. E. Ingber, M. Lawrence, T. A. Springer, and C. Lechene. 1991. Multiple integrins share the ability to induce elevation of intracellular pH. Exp. Cell Res. 195:533.
21. van Seventer, G. A., Y. Shimizu, K. J. Horgan, G. E. Luce, D. Webb, and S. Shaw. 1991. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/ LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Eur. J. Immunol. 21:1711.
22. Thomas, K. R., and M. R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503.
23. Fung-Leung, W.-P., M. W. Schilham, A. Rahemtulla, T. M. Kündig, M. Vollenweider, J. Potter, W. van Ewijk, and T. W. Mak. 1991. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65:443.
24. Doetschman, T. C., H. Eistetter, M. Katz, W. Schmidt, and R. Kemler. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27.
25. Hooper, M., K. Hardy, A. Handyside, S. Hunter, and M. Monk. 1987. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:292.
26. Cai, Z., and J. Sprent. 1994. Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179:2005.
27. Rothlein, R., and T. A. Springer. 1986. The requirement for lymphocyte function-associated antigen I in homotypic leukocyte adhesion simulated by phorbol ester. J. Exp. Med. 163:1112.
28. Hanna, N. 1982. Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res. 42:1337.
29. Humphries, M. J., K. Matsumoto, S. L. White, R. J. Molyneux, and K. Olden. 1988. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res. 48:1410.
30. Hellstrand, K., A. Asea, and S. Hermodsson. 1990. Role of histamine in natural killer cell-mediated resistance against tumor cells. J. Immunol. 145:4365.
31. Pope, B. L., J. Sigindere, E. Chourmouzis, P. MacIntyre, and M. G. Goodman. 1994. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine. Cancer Immunol. Immunother. 38:83.
32. Karre, K., G. O. Klein, R. Kiessling, G. Klein, and J. C. Roder. 1980. In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige/nude and wild-type hosts on C57BL background. Int. J. Cancer 26:789.
33. Talmadge, J. E., K. M. Meyers, D. J. Prieur, and J. R. Starkey. 1980. Role of NK cells in tumor growth and metastasis in beige mice. Nature 284:622.
34. Zhou, L., B. L. Pope, E. Chourmouzis, W.-P. Fung-Leung, and C. Y. Lau. 1996. Tepoxalin blocks neutrophil migration into cutaneous inflammatory sites by inhibiting Mac-1 and E-selectin expression. Eur. J. Immunol. 26:120.
35. Robey, E., and B. J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev Immunol. 12:675.
36. Singer, K. H., S. M. Denning, L. P. Whichard, and B. F. Haynes. 1990. Thymocyte LFA-1 and thymic epithelial cell ICAM-1 molecules mediate binding of activated human thymocytes to thymic epithelial cells. J. Immunol. 144:2931.
37. Fine, J. S., and A. M. Kruisbeek. 1991. The role of LFA-1/ICAM-1 interactions during murine T lymphocyte development. J. Immunol. 147:2852.
38. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. a. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.
39. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. b. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.
40. + thymocytes. Nature 333:742.
41. Teh, H. S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Bluthmann, and H. von Boehmer. 1988. Thymic major histocompatibitity complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229.
42. Ohashi, P. S., H. Pircher, K. Bürki. R. M. Zinkernagel, and H. Hengartner. 1990. Distinct sequence of negative or positive selection implied by thymocyte T-cell receptor densities. Nature 346:861.
43. Schmits, R., T. M. Kündig, D. M. Baker, G. Shumaker, J. J. L. Simard, G. Duncan, A. Wakeham, A. Shahinian, A. van der Heiden, M. F. Bachmann, P. S. Ohashi, T. W. Mak, and D. D. Hickstein. 1996. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183:1415.
44. Sligh, J. E., Jr., C. M. Ballantyne, S. S. Rich, H. K. Hawkins, C. W. Smith. A. Bradley, and A. L. Beaudet. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 90:8529.
45. Xu, H., J. A. Gonzalo, Y. St. Pierre, I. R. Williams, T. S. Kupper, R. S. Cotran, T. A. Springer, and J.-C. Gutierrez-Ramos. 1994. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180:95.
46. Fischer, A., S. Blanche, F. Veber, F. Ledeist, I. Gerota, M. Lopez, A. Durandy, and C. Griscelli. 1986. Correction of immune disorders by HLA matched and mismatched bone marrow transplantation. In Recent Advances in Bone Marrow Transplantation. R. P. Gale, ed. Alan R. Liss, New York, p. 368.
47. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
48. Isobe, M., H. Yagita, and K. Okumura. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255: 1125.
49. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
50. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
51. Damle, N. K., K. Klussman, and A. Aruffo. 1992. a. Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. J. Immunol. 148:665.
52. Damle, N. K., K. Klussman, P. S. Linsley, and A. Aruffo. 1992. b. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J. Immunol. 148:1985.
53. Damle, N. K., K. Klussman, P. S. Linsley, A. Aruffo, and J. A. Ledbetter. 1992. c. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J. Immunol. 149:2541.
54. Green, J. M., X.-G. Zheng, Y. Shimizu, C. B. Thompson, and L. A. Turka. 1994. T cell receptor stimulation, but not CD28 co-stimulation, is dependent on LFA-1-mediated events. Eur. J. Immunol. 24:265.
55. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
56. Warner, J. F., and G. Dennert. 1985. Bone marrow graft rejection as a function of antibody-directed natural killer cells. J. Exp. Med. 161:563.
57. Reisner, Y., I. Ben Bassat, D. Dour, A. Kaploon, E. Schwartz, and B. Ramot. 1986. Demonstration of clonable alloreactive host T cells in a primate model for BMT. Proc. Natl. Acad. Sci. USA 83:4012.
58. Bierer, B. E., S. G. Emerson, J. Antin, R. Maziarz, J. M. Rappeport, B. R. Smith, and S. J. Burakoff. 1988. Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation 46:835.
59. Le Deist, F., S. Blanche, H. Keable, C. Gaud, H. Pham, B. Descamp-Latscha, V. Wahn, C. Griscelli, and A. Fischer. 1989. Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency. Blood 74:512.
60. Davignon, D., E. Martz, T. Reynolds, K. Kurzinger, and T. A. Springer. 1981. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA 78:4535.
61. Sanchez-Madrid, F., A. M. Krensky, C. F. Ware, E. Robbins, J. L. Strominger. S. J. Burakoff, and T. A. Springer. 1982. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci. USA 79:7489.
62. Mentzer, S. J., A. M. Krensky, and S. J. Burakoff. 1986. Mapping functional epitopes of the human LFA-1 glycoprotein: monoclonal antibody inhibition of NK and CTL effectors. Hum. Immunol. 17:288.
63. Schmidt, T. E., O. Bartley, H. Levine, S. F. Schlossman, and J. Ritz. 1985. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J. Immunol. 135:1020.
64. Issekutz, T. B. 1992. Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1. J. Immunol. 149:3394.
65. Scheynius, A., R. L. Camp, and E. Puré. 1993. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol. 150:655.
66. Issekutz, T. B. 1991. Effect of antigen challenge on lymph node lymphocyte adhesion to vascular endothelial cells and the role of VLA-4 in the rat. Cell. Immunol. 138:300.
67. Kavanaugh, A. F., E. Lighlfoot, P. E. Lipsky, and N. Oppenheimer-Marks. 1991. Role of CD11/CD18 in adhesion and transendothelial migration of T cells: analysis utilizing CD18-deficient T cell clones. J. Immunol. 146:4149.
68. Vennegoor, C. J. G. M., E. van de Wiele-van Kemenade, R. J. F. Hiujbens, F. Sanchez-Madrid, C. J. Melief, and C. G. Figdor 1992. Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells: indication for a new adhesion pathway. J. Immunol. 148:1093.